University of Kansas School of Medicine is a clinical research site located in Kansas City, Kansas, United States 66160-8500.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
University of Kansas School of Medicine has participated in 7 clinical trials with 2 currently active.
Therapeutic areas: Fabry Disesase, Cystic Fibrosis, Chronic Bronchitis.
Sponsors: GC Biopharma Corp, Nabriva Therapeutics AG, Gala Therapeutics, Inc..
Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
University of Kansas School of Medicine has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Kansas School of Medicine has 7 clinical trials on record, with 2 currently active. Their work covers Fabry Disesase, Cystic Fibrosis, Chronic Bronchitis.
Yes — University of Kansas School of Medicine holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.